Maharashtra FDA Finds Huge Markups on Hospital Consumables, Tukaram Mundhe Seeks Central Price Controls

Brief by Shorts91 Newsdesk / 12:50pm on 16 Sep 2026,Wednesday India

A Maharashtra FDA survey has found major differences between procurement costs and prices charged for commonly used hospital consumables. An IV set purchased for ₹11.05 was reportedly sold for ₹325, representing a 2,841% margin. A 10 ml syringe costing ₹6.75 was sold for ₹57.20, while a nebuliser mask bought for ₹45 was sold for ₹652. Maharashtra FDA Commissioner Tukaram Mundhe has urged the Centre to review pricing regulations and bring commonly used inpatient surgical consumables under the Drugs (Prices Control) Order. He also suggested trade-margin limits and stronger monitoring to reduce financial burdens on hospital patients. 

Read More at NDTV

Menu